Answer
Semaglutide lowers glucagon secretion when blood glucose is high as part of its glucose-dependent blood-glucose-lowering effect, but does not impair glucagon secretion during hypoglycaemia.
Sources for this answer
- Wegovy 2.4 mg, FlexTouch solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 16Document updated
Sources checked